TNXP: Secures Commercial Payer Coverage for Tonmya to Provide Access for ~35 Million U.S. Patients
On May 11, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) announced financial results for the first quarter of 2026 and provided a business...
85 Views
TNXP: ~2500 Patients Have Initiated Treatment with Tonmya Following November 2025 Commercial Launch
On March 12, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) announced financial results for the fourth quarter and full year ending December 31,...
172 Views
TNXP: Tonix Now a Commercial Stage Company Following the Launch of Tonmya
On November 10, 2025, Tonix Pharmaceuticals Holding Corp. (TNXP) announced financial results for the third quarter of 2025 and provided a business...
269 Views
TNXP: Tonmya Approved by FDA
On August 15, 2025, Tonix Pharmaceuticals Holding Corp. (TNXP) announced that the U.S. Food and Drug Administration (FDA) approved Tonmya ...
299 Views
TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500
Tonix Pharmaceuticals Holding Corp. (TNXP) recently announced certain preliminary financial information and selected preliminary operating results...
271 Views